Kilitch Drugs (India) Ltd.

213.70 +8.80 ▲4.3%

26 May 2023, 04:01:00 PM
Volume: 1,187

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kilitch.com
Market Cap 332.99 Cr.
Enterprise Value(EV) 337.44 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 6.28 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 34.04 Trailing Twelve Months Ending 2022-12
Industry PE 31.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 93.99 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.27 Calculated using Price: 213.70
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.56 Cr. 15,582,319 Shares
FaceValue 10
About Kilitch Drugs (India) Ltd.
Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.

Kilitch Drugs (India) Ltd. Delivery

Delivered Qty
Traded Qty

Kilitch Drugs (India) Ltd. Performance

1 Day
+4.29%
1 Week
-2.82%
1 Month
+22.11%
3 Month
+54.80%
6 Month
+30.07%
1 Year
+40.55%
2 Year
+17.74%
5 Year
+137.44%
10 Year
+889.35%

Kilitch Drugs (India) Ltd. Fundamental Ratios

9 years 2012-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 78.03 -0.25 -9.91 -8.59 4.95 3.36 0.71 3.09 4.73
Return on Capital Employed (%) 76.95 -0.74 -10.11 -8.69 6.08 7.59 1.95 4.40 7.26
Return on Assets (%) 46.26 -0.19 -9.25 -7.86 4.36 2.85 0.59 2.19 3.03

Kilitch Drugs (India) Ltd. Balance Sheet

Particulars 10 years 2012-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 115 120 109 101 112 121 118 127 139 145
Non Curr. Liab. 1 -1 -1 -2 -2 -1 -1 -1 -1 -1
Curr. Liab. 60 7 8 12 15 20 22 73 69 64
Minority Int. 1 1 2 2 2 1 0
Equity & Liab. 177 126 116 110 126 143 142 202 208 208
Non Curr. Assets 10 79 68 62 63 78 86 122 94 104
Curr. Assets 167 47 47 49 63 65 56 80 114 104
Misc. Exp. not W/O 0 0
Total Assets 177 126 116 110 126 143 142 202 208 208

Kilitch Drugs (India) Ltd. Profit and Loss

Particulars 10 years 2012-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 108 19 21 29 51 82 53 69 114 131
Other Income 1 3 3 1 3 5 5 3 3 2
Total Income 109 22 24 30 54 88 58 71 117 133
Total Expenditure -95 -21 -25 -29 -46 -76 -53 -63 -104 -114
PBIDT 14 1 -2 1 9 11 5 8 13 19
Interest -3 0 0 0 0 -1 -1 -1 -1 -4
Depreciation -5 -2 -10 -10 -2 -2 -2 -2 -2 -4
Taxation -21 1 0 0 -1 -5 -1 -1 -3 -3
Exceptional Items 92
PAT 76 0 -11 -9 5 4 1 4 6 8
Minority Interest 1 0 1 2
Share Associate
Other Related Items
Consolidated Net Profit 77 0 -11 -9 5 4 1 4 7 10
Adjusted EPS 58 0 -8 -7 4 2 1 2 5 6

Kilitch Drugs (India) Ltd. Cash Flow

Particulars 10 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 22 -29 -8 17 1 1 0 4 46 6
Cash Fr. Inv. -24 41 -31 -20 -2 -4 -14 -10 -38 -15
Cash Fr. Finan. 7 -9 0 0 0 6 17 1 2 7
Net Change 6 2 -39 -2 0 2 3 -5 10 -2
Cash & Cash Eqvt 9 12 5 3 2 5 8 3 13 10

Kilitch Drugs (India) Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 68.63 68.33 68.33 68.25 68.25 68.25 68.25 68.25 68.25
Public 31.37 31.67 31.67 31.75 31.75 31.75 31.75 31.75 31.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kilitch Drugs (India) Ltd. Announcements

Tue, 23 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 please find enclosed herewith Annual Secretarial Compliance Report for the financial year ended 31st March 2023 issued by practicing company secretary Deep Shukla & Associates dated 10th May 2023
Wed, 17 May 2023
Board Meeting Intimation for Considering The Financial Results For The Quarter And Year Ended 31St March 2023
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended this is to inform you that the meeting of the Board of Directors of the Company will be held on Monday 29th May 2023 inter-alia to consider and approve the audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March 2023
Fri, 12 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirement) Regulations 2015 we hereby intimate you that the Company has received letter in relation with loss of Share Certificate from the Registrar and Share Transfer Agents of the Company i.e. Link Intime India Private Limited. Further the request for issue of duplicate share certificate has also been received with respect to the same.

Kilitch Drugs (India) Ltd. Technical Scans

Fri, 26 May 2023
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Kilitch Drugs (India) Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Kilitch Drugs (India) Ltd. FAQ's

What is Kilitch Drugs(India) share price?

Can I buy Kilitch Drugs(India) shares now?

What is the Market Cap of Kilitch Drugs(India)?

What are the key metrics to analyse Kilitch Drugs(India)?

What is the 52 Week High and Low of Kilitch Drugs(India)?

What is the trend of Kilitch Drugs(India) share price?